Boyds published the September edition of its Regulatory Intelligence Digest, which includes updates from the FDA, EMA, MHRA, and ICH.
Published
Signal category
Research & Knowledge
Quote
“The September edition of our Regulatory Intelligence Digest is out now, bringing together the latest updates from the FDA, EMA, MHRA, ICH and other key regulatory agencies.”
— Boyds team
Company
Boyds
Over 20 years supporting the global development of cutting-edge medicines for the benefit of patients.
- Industry
- Business Consulting and Services
- Location
- Crewe, GB
- Company size
- 59 employees
At Boyds, our goal is to facilitate the translation of cutting-edge science into medicinal products which benefit patients. We understand how challenging this can be, both technically and commercially. Our service is designed to provide crucial experience and assistance whenever you need it, in order to bring your innovations to the marketplace as quickly and efficiently as possible. Boyds was established in 2005 and provides a range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We are headquartered in the UK with offices located in Cheshire and Cambridgeshire and also have offices in Dublin and Pennsylvania. Our consultancy services offer a cost-effective solution for those requiring expert assistance in order to expedite development, add value to their product, and reach those key milestones. Whether it relates to a single issue or a long-term commitment to your development team, we can help you chart the innovative course great science demands.
Founded 2005